Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
CMR Surgical
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Oct 2026: Stryker agreed a preferred equity investment of about $400m in CMR Surgical, with an exclusive option to buy 100% of the company, subject to regulatory approvals. This followed a $200m+ equity and debt round in Apr 2025.
Cyber & information governance
Jun 2026: CMR Surgical began a US recall (FDA Class 2) of two Versius surgeon consoles after secure boot was not enabled in manufacturing, which it said presented a potential cybersecurity risk; it is configuring secure boot on affected units. NHS DSPT status not yet checked.
Regulatory & clinical safety
Jun 2026: FDA Class 2 recall of two US Versius surgeon consoles over secure boot not being enabled (open as posted). Aug 2025: Germany's BfArM published a CMR Surgical advisory notice for the Versius Surgeon Console; its content was not stated on the summary page.
Contract performance
No contract terminations, disputes or troubled implementations involving CMR Surgical found in HSH's search of the last 24 months. Apr 2025: the company said Versius had been used in over 30,000 cases in 30+ countries.
Competitors
No competitors linked yet.